Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Twelve-Week, Double-Blind, Placebo-Controlled, Randomized, Multicenter Study With Follow-up Evaluating the Safety and Efficacy of Varenicline Tartrate ( CP-526,555) in Comparison to Zyban for Smoking Cessation

NCT00141206 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00141206
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00141206 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Twelve-Week, Double-Blind, Placebo-Controlled, Randomized, Multicenter Study With Follow-up Evaluating the Safety and Efficacy of Varenicline Tartrate ( CP-526,555) in Comparison to Zyban for Smoking Cessation
Lead sponsor
Pfizer
Phase
Phase 3
Overall status
Completed
Start date
May 31, 2003
Completion date
April 30, 2005
Enrollment
1,005
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

smoking cessation